Bristol Myers Squibb (BMY.US) Stock Community - Hot Topic Discussions

Quote List Quote List

Event Tracking

Dec5

Breyanzi Approved by FDA for Treatment of Marginal Zone Lymphoma

01:15

Dec3

Terray Therapeutics Reaches Milestone in Drug Discovery Using EMMI Platform

16:18

Bristol Myers Squibb to recruit more participants for Cobenfy's late-stage trial

13:28

Bristol Myers Squibb Continues Phase 3 Study for Alzheimer's Psychosis Treatment

11:59

Cantor Fitzgerald Maintains Neutral Rating for BMY and Sees Positive Outlook for Milvexian Project

07:37

Dec2

Edgestream Partners L.P. Increased Position in Bristol-Myers Squibb

09:41

Schedules & Filings

Schedules

Filings

Nov3

Distribution Plan(EST)

Cash dividend 0.62 USD

Oct30

Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 12.22 B, Net Income 2.201 B, EPS 1.08

Oct3

Distribution Plan(EST)

Cash dividend 0.62 USD

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change